AI-Powered Clinical Document Intelligence: Automating Data Extraction, Standardization, and Review

Abstract

The pharmaceutical and life sciences industry continues to struggle with extracting, standardizing, and ensuring regulatory compliance for unstructured clinical documents. While natural language processing and machine learning offer theoretical solutions, existing literature treats clinical document intelligence (CDI) as isolated technical problems rather than integrated regulatory systems. This article synthesizes current knowledge on transformer-based NLP, optical character recognition, and automated coding within the constraints of FDA 21 CFR Part 11 and AI/ML validation frameworks. The article critically examines seven domain areas—NLP architectures, document processing, coding automation, workflow integration, cloud infrastructure, regulatory compliance, and responsible AI, while identifying persistent gaps: validation methodologies suited to stochastic systems, evidence-based bias mitigation procedures, and deployment considerations that bridge technical capability and regulatory reality. By positioning clinical document intelligence as a regulatory systems integration challenge rather than a pure machine learning problem, this article provides a framework for practitioners and researchers to evaluate whether existing techniques adequately address pharmaceutical operational requirements. The article does not claim to advance the underlying technologies but rather articulates how known techniques intersect with regulated environments, where human oversight, explainability, and equity must be engineered into systems from the start.